dca pharmacy tirzepatide 22% body weight Tirzepatide Micro-Dose Program | Weight

In the SURMOUNT-1 trial, patients on tirzepatides highest dose (15mg weekly) lost an average of 20.9% of body weight over 72 weeks

Managing the side effects makes it more likely youll stay on the medication to reap the benefits

Ozempic made a splashy debut in 2017 with a catchy jingle and celebrity following, and Mounjaro came onto the scene five years later as another impressive type 2 diabetes medication that delivers impactful glucose management results along with significant weight loss

All of these adverse events were classified as grade 1 and resolved spontaneously without intervention

Smaller dose increments, such as 1.25 mg increases instead of 2.5 mg, can also reduce the severity of symptoms